Compare PYPD & IZEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
IZEA Worldwide Inc is a create economy, specializing in providing software solutions and professional services that connect brands with a broad spectrum of social influencers and content creators. It's a pioneering marketing technology company that offers cutting-edge software and professional services, empowering brands to engage and transact with a diverse range of social influencers and content creators. Its brands are The Creator Marketplace, IZEA Flex, and Full-Service Influencer Marketing. Its geographic areas are North America, APAC, and other.